Skip to Main Content
Access your saved content
Productivity challenges are not new to the pharmaceutical industry. They have, however, been complicated by new pressures and industry-wide trends—from the staggering patent cliffs ahead and increased pressure from payers to the potential opportunities created by emerging global markets and health care consumerism. As a result, R&D organizations are looking at a challenging future. How can they survive in a do-better-with-less climate of reduced resources
and widespread cost cutting?
Now is the time for R&D organizations to rethink how they work—from changing operating models, to focusing on continuous improvement and reassessing funding and resource streams.
The world’s leading life sciences companies turn to Accenture’s comprehensive and R&D-specific management consulting services to make
transformational changes that deliver portfolio, organizational and business improvements. Our work spans the entire R&D lifecycle, and helps our clients to deliver positive outcomes in the following areas:
R&D and Functional strategies
R&D Operating Models
Accenture’s life sciences R&D-specific management consulting services are unique because of our:
Skip Footer Links